ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 34 filers reported holding ENZYMOTEC LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 327,962 | $7,222,000 | 2.32% |
| Matterhorn Capital Management, LLC | 123,706 | $2,708,000 | 1.25% |
| ALYDAR PARTNERS LLC | 311,350 | $6,856,000 | 0.68% |
| Perceptive Advisors | 214,219 | $4,717,000 | 0.50% |
| Paulson & Co. | 4,271,230 | $94,052,000 | 0.46% |
| Visium Asset Management, LP | 1,140,000 | $25,103,000 | 0.41% |
| FRIESS ASSOCIATES LLC | 122,500 | $2,697,000 | 0.21% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 263,653 | $5,806,000 | 0.18% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 167,125 | $3,680,000 | 0.14% |
| Alyeska Investment Group, L.P. | 185,533 | $4,085,000 | 0.11% |